A detailed history of Two Sigma Investments, LP transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 81,091 shares of OMGA stock, worth $10,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,091
Previous 73,722 10.0%
Holding current value
$10,541
Previous $152,000 35.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.22 - $2.25 $8,990 - $16,580
7,369 Added 10.0%
81,091 $98,000
Q2 2024

Aug 14, 2024

BUY
$1.86 - $3.2 $137,122 - $235,910
73,722 New
73,722 $152,000
Q4 2023

Feb 14, 2024

BUY
$1.35 - $3.21 $40,679 - $96,726
30,133 New
30,133 $90,000
Q2 2022

Aug 15, 2022

SELL
$2.01 - $7.19 $21,320 - $76,264
-10,607 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.24 - $14.04 $66,187 - $148,922
10,607 New
10,607 $66,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $6.22M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.